The market for regenerative artificial skin was estimated to be worth USD 2.1 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% to reach USD 5.6 billion by 2032.
.jpg
"The Global Regenerative Artificial Skin Market 2022-2032 (USD Billion)")
The global regenerative artificial skin market is anticipated to grow at 5.5% CAGR during the forecast period. Increase in prevalence of chronic wounds, surging cases of burns and traumatic injuries across the globe coupled with rapid advances in healthcare-related technologies, such as tissue engineering and biotechnology are significant driving forces in the regenerative artificial skin industry.
Artificial Skin is a synthetic counterpart for human skin that can stimulate skin regeneration, improving the treatment of severe burns and injuries dramatically. Apligraf, OrCel, Dermagraft, Biobrane, and Integra are some of the synthetic skin substitutes available in the market. Chronic wounds including diabetic foot ulcers, pressure ulcers, and venous leg ulcers are difficult and expensive to heal posing huge cost burden on the healthcare systems. Growing adoption of sedentary lifestyle, unhealthy food habits, aggravating chronic diseases such as obesity and diabetes are major factors for the formation of chronic wounds. Thus, the need for rapid wound-healing has significantly increased owing to the increasing number of patients suffering from diabetes and obesity. According to International Diabetes Federation (IDF), 463 million people were living with diabetes globally in 2019 and this number is expected to reach 700 million by 2045. These factors are anticipated to fuel the demand for regenerative artificial skin over the forecast timeframe.
Moreover, rapid rise in traumatic injuries and burn cases across the globe are expected to drive the demand for regenerative medicine in the future. However, lack of healthcare infrastructure and inadequate access to medical services in low and middle income countries.is expected to hinder the growth of the market over the forecast period.
The global regenerative artificial skin market is categorized based on material type, end-users, and region. On the basis of material type, the global regenerative artificial skin market is segregated into permanent, temporary and composites skin material. Composite skin material is anticipated to grow at a healthy growth rate owing to its wide adoption for healing burn wounds. By end-users, burn care centers segment is anticipated to grow at a lucrative rate over the forecast period. Geographically, North America dominated the global regenerative artificial skin market in 2020, however, Asia Pacific is expected to be the fastest growing region by 2028.
Key players operating in the global regenerative artificial skin market include Integra LifeSciences Corporation, Smith & Nephew plc, Mölnlycke Health Care AB, 3M, Medtronic plc, Mimedx Group, Avita Medical, Solsys Medical, Baxter Corporation, and Organogenesis among others.
Regenerative Artificial Skin Market Scope
| Metrics | Details |
| Base Year | 2022 |
| Historic Data | 2022-2023 |
| Forecast Period | 2022-2032 |
| Study Period | 2022-2032 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2032 | USD 5.6 billion |
| Growth Rate | CAGR of 9.8% during 2022-2032 |
| Segment Covered | Material Type,End-users, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Integra LifeSciences Corporation, Smith & Nephew plc, Mölnlycke Health Care AB, 3M, Medtronic plc, Mimedx Group, Avita Medical, Solsys Medical, Baxter Corporation among others. |
Key Segments of the Global Regenerative Artificial Skin Market
Material Type Overview
- Temporary Skin Material
- Permanent Skin Material
- Composite Skin Material
End-users Overview
- Hospitals
- Clinics
- Burn Care Centers
Regional Overview
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC countries
- South Africa
- Rest of Middle East & Africa
Reasons for the study
- Increase in burn cases and traumatic injuries across the globe
- Surge in incidence of chronic disorders such as diabetes and obesity
What does the report include?
- The study on the global regenerative artificial skin market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s Five Forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of material type, and end-users. Moreover, the study on regenerative artificial skin market provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global regenerative artificial skin market is suitable for all the players across the value chain including raw material suppliers, hospitals, clinics, burn care centers, medical device manufacturers, healthcare organizations, distributors, suppliers and technology geeks
- Venture capitalists and investors looking for more information on the future outlook of the global regenerative artificial skin market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global regenerative artificial skin market
Frequently Asked Questions (FAQ) :
The major contenders in the global market are Integra LifeSciences Corporation, Smith & Nephew plc, Mölnlycke Health Care AB, 3M, Medtronic plc, Mimedx Group, Avita Medical, Solsys Medical, Baxter Corporation among others.
The regenerative artificial skin market is growing at a CAGR of 9.8 % over the forecast period.
The Global regenerative artificial skin market is Segmented on the Material Type,End-users, Regions.
The skin is a delicate organ that is impossible to repair when it is irreversibly compromised by wounds, or cancer. While autologous skin transplantation is still the most effective procedure for patients with severe skin loss, there are now a variety of commercially available products that can be used to temporarily or permanently replace the skin. The current trend for burn wound treatment has moved to a more holistic approach to long-term type and function of healed burn wounds, as well as improved quality of life. As a result, numerous skin substitutes have emerged in the treatment of acute burn injury as well as post-burn reconstructions. Skin substitutes play a significant role in the treatment of multiple etiologies of deep dermal and full thickness wounds. Artificial skin is usually created with the aid of collagen, which is easily absorbed by the human body. The regeneration of fresh skin in the infected area is aided by artificial skin. The skin substitutes have a number of benefits, including a quick wound covering solution that may need a less vascularized wound bed, an improvement in the dermal component of the healed wound, the reduction or elimination of wound healing inhibitory factors, a reduced inflammatory reaction, and related scarring
The global regenerative artificial skin market has been segmented based on product, wound type, end-users, and region. Based on material type, the regenerative artificial skin market is segmented into permanent, temporary, and composite skin material. Composite skin material is anticipated to grow at a healthy CAGR during the forecast period. Composite skin materials are majorly used for the treatment of acute burn wounds. The biological skin substitutes have the ability to improve healing rate and mitigate risks in a variety of other skin wounds, including burn injuries, pressure, ischemia, trauma, surgery, and skin diseases, among others. All such factors will positively influence the growth of the segment in the coming years.
Based on end-users, regenerative artificial skin market is segmented into hospitals and clinics, ambulatory surgical centers and others. Hospitals & clinics dominated the global regenerative artificial skin market in 2019. Deep skin wounds and cosmetic surgery are both treated using regenerative artificial skin technologies in hospitals. Chronic wounds are treated with artificial skin by healthcare providers. To treat burned skin, specialized burn care centers make effective use of artificial skin technologies.
The global regenerative artificial skin market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global regenerative artificial skin market in 2020, however Asia Pacific is expected to grow at a highest pace through 2028.
.png "Global Regenerative artificial skin Market Share by Region (2019)")
High prevalence of burn injuries in the U.S. is a key growth rendering driver expected to boost the regenerative artificial skin market in the region. It is estimated that, the number of people injured by burns in the U.S. per year is estimated to be about 1.5 million. Annually 75,000 burned patients need inpatient treatment, with 5000 to 12,000 dying as a result of their burns. Furthermore, wide availability of regenerative artificial skin is other major factor likely to propel the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. The rapidly rising target population in countries such as India and China provide immense growth opportunities. Furthermore, rise in burn injuries and accidents will fuel the need for regenerative artificial skin over the coming years.